Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.58 USD | +5.08% |
|
-7.00% | -28.37% |
06-05 | Transcript : Syros Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
05-14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.37% | 149M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals Names New CEO; to Cut Staff by 35%; Shares Drop